Liver Cancer

>

Latest News

MEV01 trial results show that the test achieved an 86% early-stage sensitivity and 88% specificity in surveillance of HCC among patients with cirrhosis.
FDA Grants EvoLiver Biopsy Test Breakthrough Device Designation for HCC

April 23rd 2025

MEV01 trial results show that the test achieved an 86% early-stage sensitivity and 88% specificity in surveillance of HCC among patients with cirrhosis.

FDA OKs Nivolumab/Ipilimumab in Unresectable/Metastatic HCC
FDA OKs Nivolumab/Ipilimumab in Unresectable/Metastatic HCC

April 11th 2025

Most recently, the FDA accepted a second NDA for camrelizumab/rivoceranib as a treatment for patients with unresectable HCC in October 2024.
FDA Issues Second Camrelizumab/Rivoceranib CRL in Hepatocellular Carcinoma

March 21st 2025

FDA Grants Fast Track Designation to Amezalpat Combination in HCC
FDA Grants Fast Track Designation to Amezalpat Combination in HCC

February 11th 2025

Findings from the CheckMate 9DW trial support the CHMP’s recommendation for approving nivolumab/ipilimumab for those with unresectable HCC.
Nivolumab Combo Earns Positive CHMP Opinion in Advanced Liver Cancer

February 1st 2025

Latest CME Events & Activities

Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®

View More

BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC

View More

Go To PER in Chicago

May 30, 2025 - June 3, 2025

Register Now!

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting

View More

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

View More

Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers

View More

<1234